Twitter Beğeni Hilesi

🗣️ New clinical trial: Compared to aspirin alone, rivaroxaban + aspirin significantly improves walking distance in high-risk patients with peripheral artery disease who have intermittent claudication. 1/2

In June 2024, the Supreme Court issued an order halting implementation of a regulation intended to limit the interstate spread of ozone-forming emissions. The decision could endanger human health. Read the full Perspective: nej.md/3AKxNZ2

Institutional special-needs plans could warrant further investigation as a value-based model for financing care provided to long-stay nursing home residents. Read the full Perspective: nej.md/3AJlb4z

Original Article: Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma nej.md/3Xa9oDT Editorial: A Late-Arriving but Welcome Advance in Sarcoma Therapy nej.md/3z8Bibj #Oncology